电泳市场规模、份额和成长分析（按产品类型、应用、最终用户和地区）：产业预测（2024-2031）

2022年全球电泳市场规模为27.7亿美元，从2023年的29.3亿美元成长到2031年的45.6亿美元，在预测期间（2024-2031年）预计复合年增长率为5.7%。

市场洞察表明，对慢性病管理的需求不断增长，特别是心血管疾病、癌症和个人化医疗，正在推动强劲的成长。世界卫生组织 (WHO) 预测，新增癌症患者数量将从 2022 年的 2,000 万增加到 2050 年的 3,500 万，从而迫切需要先进的诊断技术。电泳对于基因组学、蛋白质组学和个人化治疗至关重要，产业和学术界之间的合作正在不断加强，创新也不断促进。这些伙伴关係关係利用最尖端科技来发现生物标记并在分子层面上了解疾病机制，从而提供针对个体遗传特征的治疗方法。此外，先进电子系统的整合有望提高诊断和评估的准确性和效率，从而导致医疗解决方案的重大进步。

目录

介绍

• 分析目的
• 市场范围
• 定义

分析方法

• 资讯采购
• 次要/主要资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及前景

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特分析及影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考虑因素

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场魅力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 监管环境
• 专利分析
• 案例研究

全球电泳市场规模/复合年增长率：依产品类型划分（2024-2031）

• 市场概况
• 电泳试剂
  • 凝胶
  • 缓衝
  • 染料
  • 其他的
• 电泳系统
  • 凝胶电泳系统
  • 毛细管电泳系统
  • 微晶片电泳系统
• 凝胶文件系统
• 软体

全球电泳市场规模/复合年增长率：依应用分类（2024-2031）

• 市场概况
• 调查
  • 蛋白质体学
  • 基因组学
  • 药物发现
• 诊断
  • 血红素分析
  • 蛋白质分析
  • DNA 和 RNA 分析
• 品管和过程检验

全球电泳市场规模/复合年增长率：依最终用户划分（2024-2031）

• 市场概况
• 学术研究所
• 製药和生物技术公司
• 医院/诊断中心
• 其他的

全球电泳市场规模/复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市场占有率（2023年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• GE Healthcare
• Agilent Technologies, Inc.
• Danaher Corporation
• PerkinElmer, Inc.
• Merck KGaA
• QIAGEN NV
• Lonza Group Ltd.
• Harvard Bioscience, Inc.
• Takara Bio Inc.
• Promega Corporation
• Analytik Jena AG
• Sebia Group
• Cleaver Scientific Ltd.

结论和建议

Global Electrophoresis Market size was valued at USD 2.77 billion in 2022 and is poised to grow from USD 2.93 billion in 2023 to USD 4.56 billion by 2031, growing at a CAGR of 5.7% during the forecast period (2024-2031).

Market insights reveal robust growth driven by escalating demand for chronic disease management, particularly in cardiovascular diseases, cancer, and personalized medicine. With the World Health Organization projecting a staggering 35 million new cancer cases by 2050, up from 20 million in 2022, the need for advanced diagnostic techniques is urgent. Increased collaborations between academia and industry are fostering innovations in electrophoresis, crucial for genomics, proteomics, and personalized therapeutics. These partnerships leverage cutting-edge technology to uncover biomarkers and understand disease mechanisms at a molecular level, thereby tailoring therapies to individual genetic profiles. Additionally, the integration of advanced electronic systems enhances accuracy and efficiency in diagnostics and assessments, positioning the market for significant advancements in healthcare solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Electrophoresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Electrophoresis Market Segmental Analysis

Global Electrophoresis Market is segmented by product type, application, end user and region. Based on product type, the market is segmented into electrophoresis reagents (gels, buffers, dyes, other), electrophoresis systems (gel electrophoresis systems, capillary electrophoresis systems, microchip electrophoresis systems), gel documentation systems and software. Based on application, the market is segmented into research (proteomics, genomics, drug discovery), diagnostics (hemoglobin analysis, protein analysis, DNA & RNA analysis) and quality control & process validation. Based on end user, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & diagnostic centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Electrophoresis Market

The global electrophoresis market is primarily driven by the growing demand for personalized medicine and enhanced diagnostic accuracy. As researchers and clinicians seek more precise diagnostic tools, the need for effective separation and analysis of biomolecules, including proteins, nucleic acids, and peptides, intensifies. Techniques such as gel electrophoresis and capillary electrophoresis are pivotal in this process, significantly influencing advancements in proteomics and genomics. As these fields continue to evolve, the reliance on electrophoretic methods propels market expansion, facilitating the development of tailored treatments and ensuring high accuracy in diagnostics, thus fostering further innovation and investment in the electrophoresis sector.

Restraints in the Global Electrophoresis Market

One significant restraint in the Global Electrophoresis market is the elevated expenses linked to equipment and consumables. These high costs can hinder widespread adoption, particularly among smaller laboratories that require sophisticated devices for precise electrophoresis analysis. While basic electrophoresis techniques can be straightforward and cost-effective, more advanced methods-such as two-dimensional gel electrophoresis (2D-GE) and capillary electrophoresis (CE)-demand both a systematic approach and higher financial investment. This financial barrier can make it challenging for smaller organizations to access and implement these advanced technologies, limiting their participation in the evolving electrophoresis landscape.

Market Trends of the Global Electrophoresis Market

The Global Electrophoresis market is witnessing a significant trend towards the integration of automation and miniaturization, reshaping its landscape. Automated systems enhance throughput and accuracy while minimizing manual intervention, appealing to high-demand laboratories and clinics. Additionally, the miniaturization of electrodes facilitates the development of portable electrophoresis systems, catering to point-of-care testing and field applications. This dual focus not only optimizes laboratory efficiencies but also resonates with the growing need for cost-effective and versatile solutions in the healthcare sector. As such, the market is expected to expand, driven by innovations that enhance functionality and accessibility in electrophoretic techniques.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Electrophoresis Market Size by Product Type & CAGR (2024-2031)

• Market Overview
• Electrophoresis Reagents
  • Gels
  • Buffers
  • Dyes
  • Other
• Electrophoresis Systems
  • Gel Electrophoresis Systems
  • Capillary Electrophoresis Systems
  • Microchip Electrophoresis Systems
• Gel Documentation Systems
• Software

Global Electrophoresis Market Size by Application & CAGR (2024-2031)

• Market Overview
• Research
  • Proteomics
  • Genomics
  • Drug Discovery
• Diagnostics
  • Hemoglobin Analysis
  • Protein Analysis
  • DNA & RNA Analysis
• Quality Control & Process Validation

Global Electrophoresis Market Size by End User & CAGR (2024-2031)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers
• Others

Global Electrophoresis Market Size & CAGR (2024-2031)

• North America (Product Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Harvard Bioscience, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Analytik Jena AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sebia Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cleaver Scientific Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation